Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody- Associated Diseases e977 Potential Role of CHI3
![Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy | Scientific Reports Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-94298-y/MediaObjects/41598_2021_94298_Fig1_HTML.png)
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy | Scientific Reports
![Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02091/article_deploy/html/images/diagnostics-12-02091-g001.png?1661933155)
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
![Cancers | Free Full-Text | Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications Cancers | Free Full-Text | Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications](https://www.mdpi.com/cancers/cancers-15-02276/article_deploy/html/images/cancers-15-02276-g001.png)
Cancers | Free Full-Text | Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications
![Diverse types of dermatologic toxicities from immune checkpoint blockade therapy - Curry - 2017 - Journal of Cutaneous Pathology - Wiley Online Library Diverse types of dermatologic toxicities from immune checkpoint blockade therapy - Curry - 2017 - Journal of Cutaneous Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b96d51f2-6206-4d2c-83d9-eb5e1dc395b0/cup12858-fig-0001-m.jpg)
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy - Curry - 2017 - Journal of Cutaneous Pathology - Wiley Online Library
![PDF) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors PDF) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors](https://i1.rgstatic.net/publication/335905184_Variation_in_the_Assessment_of_Immune-Related_Adverse_Event_Occurrence_Grade_and_Timing_in_Patients_Receiving_Immune_Checkpoint_Inhibitors/links/5d82da2f92851ceb791417a8/largepreview.png)
PDF) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors
![Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade | Nature Communications Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-30863-x/MediaObjects/41467_2022_30863_Fig1_HTML.png)
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade | Nature Communications
![The future of cancer treatment: immunomodulation, CARs and combination immunotherapy | Nature Reviews Clinical Oncology The future of cancer treatment: immunomodulation, CARs and combination immunotherapy | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2016.25/MediaObjects/41571_2016_Article_BFnrclinonc201625_Fig1_HTML.jpg)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy | Nature Reviews Clinical Oncology
![PDF) A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab PDF) A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab](https://i1.rgstatic.net/publication/327738484_A_whole-blood_RNA_transcript-based_gene_signature_is_associated_with_the_development_of_CTLA-4_blockade-related_diarrhea_in_patients_with_advanced_melanoma_treated_with_the_checkpoint_inhibitor_tremel/links/5baae26a92851ca9ed25e3fc/largepreview.png)
PDF) A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
![The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics | Chemical Reviews The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.2c00915/asset/images/medium/cr2c00915_0042.gif)
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics | Chemical Reviews
![Frontiers | TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis Frontiers | TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis](https://www.frontiersin.org/files/Articles/922782/fimmu-13-922782-HTML/image_m/fimmu-13-922782-g001.jpg)
Frontiers | TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis
![Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?](https://www.frontiersin.org/files/Articles/574271/fimmu-11-574271-HTML-r2/image_m/fimmu-11-574271-g001.jpg)
Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
![Cancers | Free Full-Text | Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy Cancers | Free Full-Text | Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy](https://www.mdpi.com/cancers/cancers-13-00564/article_deploy/html/images/cancers-13-00564-g001.png)
Cancers | Free Full-Text | Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
![PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective | Molecular Pharmaceutics PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00353/asset/images/large/mp2c00353_0004.jpeg)